P06276 |
CHLE_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P06276 |
CHLE_HUMAN |
Tonus and reflex abnormality [ICD-11: MB47] |
P06276 |
CHLE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P06276 |
CHLE_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P06276 |
CHLE_HUMAN |
Eexposure to noxious substances harmful effect [ICD-11: NE61] |
P06276 |
CHLE_HUMAN |
Toxicity [ICD-11: N.A.] |
P06276 |
CHLE_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P22303 |
ACES_HUMAN |
Glaucoma [ICD-11: 9C61] |
P22303 |
ACES_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P22303 |
ACES_HUMAN |
Oesophageal/gastroduodenal disorder [ICD-11: DD90] |
P22303 |
ACES_HUMAN |
Pediculosis [ICD-11: 1G00] |
P22303 |
ACES_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P22303 |
ACES_HUMAN |
Parasitic worm infestation [ICD-11: 1F90] |
P22303 |
ACES_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P22303 |
ACES_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P22303 |
ACES_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P22303 |
ACES_HUMAN |
Substance abuse [ICD-11: 6C40] |
P22303 |
ACES_HUMAN |
Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] |
P22303 |
ACES_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22303 |
ACES_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
P22303 |
ACES_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P15121 |
ALDR_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P15121 |
ALDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P15121 |
ALDR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P15121 |
ALDR_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P15121 |
ALDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P15121 |
ALDR_HUMAN |
Cataract [ICD-11: 9B10] |
P15121 |
ALDR_HUMAN |
Glaucoma [ICD-11: 9C61] |
P15121 |
ALDR_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P15121 |
ALDR_HUMAN |
Gout [ICD-11: FA25] |
P15121 |
ALDR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P01375 |
TNFA_HUMAN |
Crohn disease [ICD-11: DD70] |
P01375 |
TNFA_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P01375 |
TNFA_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P01375 |
TNFA_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P01375 |
TNFA_HUMAN |
Asthma [ICD-11: CA23] |
P01375 |
TNFA_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P01375 |
TNFA_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P01375 |
TNFA_HUMAN |
Pancreatitis [ICD-11: DC31-DC34] |
P01375 |
TNFA_HUMAN |
Pemphigus [ICD-11: EB40] |
P01375 |
TNFA_HUMAN |
Psoriasis [ICD-11: EA90] |
P01375 |
TNFA_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P01375 |
TNFA_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
P01375 |
TNFA_HUMAN |
Spinal pain [ICD-11: ME84] |
P01375 |
TNFA_HUMAN |
Cystic fibrosis [ICD-11: CA25] |
P01375 |
TNFA_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
P01375 |
TNFA_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P01375 |
TNFA_HUMAN |
Systemic sclerosis [ICD-11: 4A42] |
P01375 |
TNFA_HUMAN |
Atopic eczema [ICD-11: EA80] |
P01375 |
TNFA_HUMAN |
Bowel habit change [ICD-11: ME05] |
P01375 |
TNFA_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P01375 |
TNFA_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P01375 |
TNFA_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P01375 |
TNFA_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P01375 |
TNFA_HUMAN |
Pneumonia [ICD-11: CA40] |
P01375 |
TNFA_HUMAN |
Psoriatic arthritis [ICD-11: FA21] |
P01375 |
TNFA_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P01375 |
TNFA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P01375 |
TNFA_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P01375 |
TNFA_HUMAN |
Crohn disease [ICD-11: DD70] |
P01375 |
TNFA_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P01375 |
TNFA_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
P01375 |
TNFA_HUMAN |
Infectious gastroenteritis/colitis [ICD-11: 1A40] |